In a note to investors on Sunday, analysts at Leerink Partners called these findings “compelling,” adding that they indicate ...

Moderna’s mRNA-4359, when used with Keytruda, achieves a 24% overall objective response rate in patients with melanoma, with ...

The last few months have been tumultuous for the CDC, which has seen the ouster of Director Susan Monarez and of all 17 ...

The current pharmaceutical landscape demands a change in mindset. Success requires balancing speed, cost and quality while ...

Therapies from industry leaders BioMarin and Ascendis Pharma supply a key hormone that promotes bone growth. In order to move ...

While the benefits of AI are clear, the amount data sets needed for effective AI integration is proving to be a challenge.

To drive true innovation in drug development, executives must not let excitement about the latest shiny object obscure ...

Heading into the final quarter of a year that has seen dramatic upheaval at the FDA—from the exodus of numerous senior ...

Novo had around 250 employees working on cell therapies, all of whom will be laid off, though a spokesperson declined to reveal which offices and locations will be affected.

Rocket Pharmaceuticals' strategic realignment initiative in July pulled funding from fanca-cel, which the biotech was ...

Privately-held Ferring Pharmaceuticals will part ways with up to 500 employees across its global operations in a bid to ...

Investor reaction to the deal was muted, with BMO Capital Markets analysts saying they "continue to look for more" from ...